Northeast Pharmaceutical Group Co Ltd (000597) - Total Liabilities

Latest as of March 2026: CN¥7.91 Billion CNY ≈ $1.16 Billion USD

Based on the latest financial reports, Northeast Pharmaceutical Group Co Ltd (000597) has total liabilities worth CN¥7.91 Billion CNY (≈ $1.16 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Northeast Pharmaceutical Group Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.

Northeast Pharmaceutical Group Co Ltd - Total Liabilities Trend (1993–2025)

This chart illustrates how Northeast Pharmaceutical Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Northeast Pharmaceutical Group Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Northeast Pharmaceutical Group Co Ltd Competitors by Total Liabilities

The table below lists competitors of Northeast Pharmaceutical Group Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Xinzhi Motor Co Ltd SHE:002664	China	CN¥7.85 Billion
Inner Mongolia ERDOS Resources Co Ltd B SHG:900936	China	$19.27 Billion
Jiangsu Tongxingbao Intelligent Transportation Technology Co. Ltd. A SHE:301339	China	CN¥2.83 Billion
Dazhong Transportation Group Co Ltd A SHG:600611	China	CN¥8.67 Billion
SY HOLDINGS GROUP HD-01 F:9U0	Germany	€7.18 Billion
Cardinal Infrastructure Group Inc. Class A Common Stock NASDAQ:CDNL	USA	$395.25 Million
Chengdu Spaceon Electronics Co Ltd Class A SHE:002935	China	CN¥1.37 Billion
Hanma Technology Group Co Ltd SHG:600375	China	CN¥4.94 Billion

Liability Composition Analysis (1993–2025)

This chart breaks down Northeast Pharmaceutical Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Northeast Pharmaceutical Group Co Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.15	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.42	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.58	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Northeast Pharmaceutical Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Northeast Pharmaceutical Group Co Ltd (1993–2025)

The table below shows the annual total liabilities of Northeast Pharmaceutical Group Co Ltd from 1993 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥7.22 Billion ≈ $1.06 Billion	-18.67%
2024-12-31	CN¥8.88 Billion ≈ $1.30 Billion	-12.24%
2023-12-31	CN¥10.11 Billion ≈ $1.48 Billion	+11.19%
2022-12-31	CN¥9.10 Billion ≈ $1.33 Billion	+2.34%
2021-12-31	CN¥8.89 Billion ≈ $1.30 Billion	+10.51%
2020-12-31	CN¥8.04 Billion ≈ $1.18 Billion	-6.71%
2019-12-31	CN¥8.62 Billion ≈ $1.26 Billion	+6.11%
2018-12-31	CN¥8.13 Billion ≈ $1.19 Billion	+1.01%
2017-12-31	CN¥8.05 Billion ≈ $1.18 Billion	+9.37%
2016-12-31	CN¥7.36 Billion ≈ $1.08 Billion	+16.92%
2015-12-31	CN¥6.29 Billion ≈ $920.66 Million	+8.26%
2014-12-31	CN¥5.81 Billion ≈ $850.43 Million	-2.42%
2013-12-31	CN¥5.96 Billion ≈ $871.48 Million	+40.36%
2012-12-31	CN¥4.24 Billion ≈ $620.88 Million	+2.74%
2011-12-31	CN¥4.13 Billion ≈ $604.29 Million	+16.65%
2010-12-31	CN¥3.54 Billion ≈ $518.05 Million	-12.05%
2009-12-31	CN¥4.03 Billion ≈ $589.03 Million	+59.14%
2008-12-31	CN¥2.53 Billion ≈ $370.14 Million	+16.99%
2007-12-31	CN¥2.16 Billion ≈ $316.38 Million	+68.91%
2006-12-31	CN¥1.28 Billion ≈ $187.31 Million	-8.43%
2005-12-31	CN¥1.40 Billion ≈ $204.54 Million	-9.84%
2004-12-31	CN¥1.55 Billion ≈ $226.86 Million	-6.13%
2003-12-31	CN¥1.65 Billion ≈ $241.66 Million	-8.64%
2002-12-31	CN¥1.81 Billion ≈ $264.52 Million	-3.47%
2001-12-31	CN¥1.87 Billion ≈ $274.02 Million	+6.18%
2000-12-31	CN¥1.76 Billion ≈ $258.08 Million	+1.85%
1999-12-31	CN¥1.73 Billion ≈ $253.39 Million	+8.84%
1998-12-31	CN¥1.59 Billion ≈ $232.81 Million	+29.30%
1997-12-31	CN¥1.23 Billion ≈ $180.06 Million	-41.48%
1996-12-31	CN¥2.10 Billion ≈ $307.68 Million	+25.37%
1995-12-31	CN¥1.68 Billion ≈ $245.42 Million	+50.97%
1994-12-31	CN¥1.11 Billion ≈ $162.56 Million	+5.56%
1993-12-31	CN¥1.05 Billion ≈ $154.01 Million	--

About Northeast Pharmaceutical Group Co Ltd

SHE:000597 China Drug Manufacturers - Specialty & Generic

Market Cap

$964.78 Million

CN¥6.59 Billion CNY

Market Cap Rank

#8950 Global

#2155 in China

Share Price

CN¥4.62

Change (1 day)

+0.87%

52-Week Range

CN¥4.20 - CN¥6.09

All Time High

CN¥133.00